223 related articles for article (PubMed ID: 9891531)
1. Postoperative adjuvant chemotherapy with 1-hexylcarbamoyl-5-fluorouracil in patients with colorectal cancer and at a high risk for recurrence.
Maehara Y; Sugimachi K; Ogawa M; Kakegawa T; Tomita M; Akiyoshi T
Anticancer Res; 1998; 18(6B):4629-34. PubMed ID: 9891531
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU alone as postoperative adjuvant chemotherapy for colorectal cancer.
Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Nakamura T; Nakasato H; Orita K
Anticancer Res; 2000; 20(5C):3727-34. PubMed ID: 11268446
[TBL] [Abstract][Full Text] [Related]
3. Postoperative chemotherapy for colorectal cancer by combining 5-fluorouracil infusion and 1-hexylcarbamoyl-5-fluorouracil administration after curative resection.
Sugimachi K; Maehara Y; Ogawa M; Kakegawa T; Tomita M; Akiyoshi T
Cancer; 1996 Jan; 77(1):36-43. PubMed ID: 8630937
[TBL] [Abstract][Full Text] [Related]
4. Post-operative adjuvant chemotherapy for colorectal cancer with 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration after curative resection.
Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Toge T; Nakamura T; Nakasato H; Orita K
Anticancer Res; 2001; 21(6A):4163-8. PubMed ID: 11911312
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur.
Watanabe M; Nishida O; Kunii Y; Kodaira S; Takahashi T; Tominaga T; Hojyo K; Kato T; Niimoto M; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M
Int J Clin Oncol; 2004 Apr; 9(2):98-106. PubMed ID: 15108041
[TBL] [Abstract][Full Text] [Related]
6. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
[TBL] [Abstract][Full Text] [Related]
7. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
[TBL] [Abstract][Full Text] [Related]
8. [Multicenter comparative study of the recurrence-inhibitory effect of oral fluoropyrimidine drugs in patients with colorectal cancer following curative resection].
Sadahiro S; Mitomi T; Noto T; Kumada K; Hiki Y; Yamakawa T; Amano T; Oki S; Otani Y; Oka H; Takahashi T; Takemiya S; Nishiyama K; Yamamura T; Tsuchiya S; Ogawa N;
Gan To Kagaku Ryoho; 2005 Jul; 32(7):997-1005. PubMed ID: 16044962
[TBL] [Abstract][Full Text] [Related]
9. Optimum duration of oral adjuvant chemotherapy of HCFU for colorectal cancer; review of 5-year follow-up.
Ito K; Kato T; Koike A; Miura K; Yamaguchi A; Sakou T; Takagi H
Anticancer Res; 2000; 20(6C):4681-6. PubMed ID: 11205200
[TBL] [Abstract][Full Text] [Related]
10. A multicenter randomized study comparing 5-fluorouracil continuous infusion (ci) plus 1-hexylcarbamoyl-5-fluorouracil and 5-FU ci alone in colorectal cancer.
Kotake K; Ohashi Y; Kodaira S; Koyama Y;
Oncol Rep; 2005 Jul; 14(1):129-34. PubMed ID: 15944779
[TBL] [Abstract][Full Text] [Related]
11. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.
Scheithauer W; Kornek GV; Marczell A; Karner J; Salem G; Greiner R; Burger D; Stöger F; Ritschel J; Kovats E; Vischer HM; Schneeweiss B; Depisch D
Br J Cancer; 1998 Apr; 77(8):1349-54. PubMed ID: 9579845
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized trial comparing intravenous 5-fluorouracil and oral doxifluridine as postoperative adjuvant treatment for advanced rectal cancer.
Min JS; Kim NK; Park JK; Yun SH; Noh JK
Ann Surg Oncol; 2000 Oct; 7(9):674-9. PubMed ID: 11034245
[TBL] [Abstract][Full Text] [Related]
13. [Appropriate duration of postoperative oral adjuvant chemotherapy with HCFU for colorectal cancer].
Ito K; Okushiba S; Morikawa T; Kondo S; Katoh H
Gan To Kagaku Ryoho; 2004 Jan; 31(1):55-9. PubMed ID: 14750322
[TBL] [Abstract][Full Text] [Related]
14. Optimal duration of oral adjuvant chemotherapy with Carmofur in the colorectal cancer patients: the Kansai Carmofur Study Group trial III.
Nakamura T; Ohno M; Tabuchi Y; Kamigaki T; Fujii H; Yamagishi H; Kuroda Y;
Int J Oncol; 2001 Aug; 19(2):291-8. PubMed ID: 11445841
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy of colorectal cancer.
Kemeny N; Saltz L; Cohen A
Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion.
Arkenau HT; Rettig K; Porschen R
Int J Colorectal Dis; 2005 May; 20(3):258-61. PubMed ID: 15549327
[TBL] [Abstract][Full Text] [Related]
17. [Prospective controlled study on the usefulness of Carmofur as a postoperative adjuvant chemotherapy for colorectal cancer].
Yasutomi M; Takahashi T; Kodaira S; Hojo K; Kato T; Ogawa M; Ichihashi H; Tominaga T; Tamada R; Kunii Y; Kikuchi K
Gan To Kagaku Ryoho; 1997 Oct; 24(13):1953-60. PubMed ID: 9350242
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy.
Hemminki A; Mecklin JP; Järvinen H; Aaltonen LA; Joensuu H
Gastroenterology; 2000 Oct; 119(4):921-8. PubMed ID: 11040179
[TBL] [Abstract][Full Text] [Related]
19. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
[TBL] [Abstract][Full Text] [Related]
20. Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01.
Porschen R; Bermann A; Löffler T; Haack G; Rettig K; Anger Y; Strohmeyer G;
J Clin Oncol; 2001 Mar; 19(6):1787-94. PubMed ID: 11251010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
